Fingerprint
Dive into the research topics of 'A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically